214 related articles for article (PubMed ID: 10212000)
1. Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma.
Kang YK; Kim WH; Lee HW; Lee HK; Kim YI
Lab Invest; 1999 Apr; 79(4):477-83. PubMed ID: 10212000
[TBL] [Abstract][Full Text] [Related]
2. Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma.
Isa T; Tomita S; Nakachi A; Miyazato H; Shimoji H; Kusano T; Muto Y; Furukawa M
Hepatogastroenterology; 2002; 49(45):604-8. PubMed ID: 12063950
[TBL] [Abstract][Full Text] [Related]
3. K-ras oncogene and p53 gene mutations in cholangiocarcinoma from Thai patients.
Petmitr S; Pinlaor S; Thousungnoen A; Karalak A; Migasena P
Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):71-5. PubMed ID: 9740272
[TBL] [Abstract][Full Text] [Related]
4. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between genetic alterations and clinicopathological features in intrahepatic cholangiocarcinoma].
Cong W; Finkelstein SD; Wu M
Zhonghua Bing Li Xue Za Zhi; 2001 Jun; 30(3):183-7. PubMed ID: 11866974
[TBL] [Abstract][Full Text] [Related]
6. High rates of Ki-ras point mutation in both intra- and extra-hepatic cholangiocarcinomas.
Ohashi K; Tsutsumi M; Nakajima Y; Noguchi O; Okita S; Kitada H; Tsujiuchi T; Kobayashi E; Nakano H; Konishi Y
Jpn J Clin Oncol; 1994 Dec; 24(6):305-10. PubMed ID: 7830335
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma.
Tannapfel A; Sommerer F; Benicke M; Weinans L; Katalinic A; Geissler F; Uhlmann D; Hauss J; Wittekind C
J Pathol; 2002 Aug; 197(5):624-31. PubMed ID: 12210082
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma.
Sugimachi K; Taguchi K; Aishima S; Tanaka S; Shimada M; Kajiyama K; Sugimachi K; Tsuneyoshi M
Mod Pathol; 2001 Sep; 14(9):900-5. PubMed ID: 11557787
[TBL] [Abstract][Full Text] [Related]
9. Allelotype analysis of intrahepatic cholangiocarcinoma.
Kang YK; Kim YI; Kim WH
Mod Pathol; 2000 Jun; 13(6):627-31. PubMed ID: 10874666
[TBL] [Abstract][Full Text] [Related]
10. The incidence of K-ras codon 12 mutations in cholangiocarcinoma detected by polymerase chain reaction technique.
Wattanasirichaigoon S; Tasanakhajorn U; Jesadapatarakul S
J Med Assoc Thai; 1998 May; 81(5):316-23. PubMed ID: 9623030
[TBL] [Abstract][Full Text] [Related]
11. Genetic evidence for the multicentric origin of synchronous multiple gastric carcinoma.
Kang GH; Kim CJ; Kim WH; Kang YK; Kim HO; Kim YI
Lab Invest; 1997 Mar; 76(3):407-17. PubMed ID: 9121123
[TBL] [Abstract][Full Text] [Related]
12. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma.
Nakanuma Y; Harada K; Ishikawa A; Zen Y; Sasaki M
J Hepatobiliary Pancreat Surg; 2003; 10(4):265-81. PubMed ID: 14598145
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation.
Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N
J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567
[TBL] [Abstract][Full Text] [Related]
14. K-ras codon 12 mutation determines the polypoid growth of colorectral cancer.
Chiang JM; Chou YH; Chou TB
Cancer Res; 1998 Aug; 58(15):3289-93. PubMed ID: 9699657
[TBL] [Abstract][Full Text] [Related]
15. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Matsubara T; Sakurai Y; Sasayama Y; Hori H; Ochiai M; Funabiki T; Matsumoto K; Hirono I
Cancer; 1996 Apr; 77(8 Suppl):1752-7. PubMed ID: 8608574
[TBL] [Abstract][Full Text] [Related]
16. Analysis of genetic changes in intrahepatic cholangiocarcinoma induced by thorotrast.
Kamikawa T; Amenomori M; Itoh T; Momoi H; Hiai H; Machinami R; Ishikawa Y; Mori T; Shimahara Y; Yamaoka Y; Fukumoto M
Radiat Res; 1999 Dec; 152(6 Suppl):S118-24. PubMed ID: 10564951
[TBL] [Abstract][Full Text] [Related]
17. p53 Mutations in human cholangiocarcinoma: a review.
Khan SA; Thomas HC; Toledano MB; Cox IJ; Taylor-Robinson SD
Liver Int; 2005 Aug; 25(4):704-16. PubMed ID: 15998419
[TBL] [Abstract][Full Text] [Related]
18. Analysis of p53 mutations for a mutational signature in human intrahepatic cholangiocarcinoma.
Khan SA; Taylor-Robinson SD; Carmichael PL; Habib N; Lemoine NR; Thomas HC
Int J Oncol; 2006 May; 28(5):1269-77. PubMed ID: 16596244
[TBL] [Abstract][Full Text] [Related]
19. Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas.
Foja S; Goldberg M; Schagdarsurengin U; Dammann R; Tannapfel A; Ballhausen WG
Liver Int; 2005 Dec; 25(6):1202-8. PubMed ID: 16343073
[TBL] [Abstract][Full Text] [Related]
20. Cancer genes and cholangiocarcinoma.
Petmitr S
Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 1():80-4. PubMed ID: 9656355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
